Pulse Biosciences (PLSE) Competitors

Pulse Biosciences (NASDAQ:PLSE) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk, community ranking and dividends.

Does the media prefer PLSE or IRTC?

In the previous week, iRhythm Technologies had 6 more articles in the media than Pulse Biosciences. MarketBeat recorded 8 mentions for iRhythm Technologies and 2 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 1.24 beat iRhythm Technologies' score of 0.81 indicating that Pulse Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulse Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	3 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is PLSE or IRTC more profitable?

Pulse Biosciences has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Pulse Biosciences' return on equity of -96.89% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	N/A	-96.89%	-74.83%
iRhythm Technologies	-19.14%	-118.83%	-11.34%

Which has more risk & volatility, PLSE or IRTC?

Pulse Biosciences has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500.

Do insiders and institutionals have more ownership in PLSE or IRTC?

76.9% of Pulse Biosciences shares are held by institutional investors. 71.5% of Pulse Biosciences shares are held by insiders. Comparatively, 1.1% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has preferable earnings & valuation, PLSE or IRTC?

Pulse Biosciences has higher earnings, but lower revenue than iRhythm Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$700K	1,581.90	-$42.21M	N/A	N/A
iRhythm Technologies	$618.59M	7.47	-$123.41M	-$3.14	-46.12

Does the MarketBeat Community believe in PLSE or IRTC?

iRhythm Technologies received 168 more outperform votes than Pulse Biosciences when rated by MarketBeat users. Likewise, 66.29% of users gave iRhythm Technologies an outperform vote while only 63.50% of users gave Pulse Biosciences an outperform vote.

Company	Underperform	Outperform
Pulse Biosciences	Outperform Votes 247 63.50%	Underperform Votes 142 36.50%
iRhythm Technologies	Outperform Votes 415 66.29%	Underperform Votes 211 33.71%

Do analysts recommend PLSE or IRTC?

iRhythm Technologies has a consensus target price of $136.45, suggesting a potential downside of 5.78%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
iRhythm Technologies	0 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.91

Summary

Pulse Biosciences and iRhythm Technologies tied by winning 8 of the 16 factors compared between the two stocks.